EverSource Wealth Advisors’s Tourmaline Bio TRML Stock Holding History

EverSource Wealth Advisors’s Portfolio TRML Stock Details TRML Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-183	Closed	-$8.75K	–	4450
2025 Q3	$8.75K	Buy	183 +150	+455%	+$4.16K	﹤0.01%	2890
2025 Q2	$528	Buy	+33	New	+$535	﹤0.01%	3881

EverSource Wealth Advisors's TRML Position: Q4 2025 in Review

EverSource Wealth Advisors sold out of Tourmaline Bio (TRML) in Q4 2025, closing a stake of 183 shares — an estimated $8.75K sold.

EverSource Wealth Advisors first reported a position in TRML in Q2 2025 and held it in 2 quarters. The position peaked at $8.75K in Q3 2025. 0 funds tracked by Wall St. Rank hold TRML as of Q4 2025.

EverSource Wealth Advisors reported no remaining Tourmaline Bio position as of Q4 2025 after selling out during the quarter.
EverSource Wealth Advisors sold 183 Tourmaline Bio shares in Q4 2025, an estimated $8.75K.
EverSource Wealth Advisors first reported a position in Tourmaline Bio in Q2 2025 and held it in 2 quarters.
EverSource Wealth Advisors's Tourmaline Bio position peaked at $8.75K in Q3 2025.
0 funds tracked by Wall St. Rank held Tourmaline Bio as of Q4 2025.

Based on EverSource Wealth Advisors's 13F filing for Q4 2025, filed 6 Feb 2026.